Metraipolis › archive › dc_a828ef62ae8d

Beyond priming: a sequential, feedback-guided adjuvant framework for therapeutic cancer peptide vaccines in immunologically cold tumors — Europe PMC PMID:42238584

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42238584
DOI
10.3389/fimmu.2026.1835816
License (as archived)
solo-consultazione
Archived
2026-11-01T14:54:50.327Z
SHA-256 of the archived text
a4142f04600f9dc1086a213dc7e6de2bb06eb6ec9231838d603ed978e5c13efe
Stable URL of this page
https://metraipolis.com/documento/dc_a828ef62ae8d

How to cite

Beyond priming: a sequential, feedback-guided adjuvant framework for therapeutic cancer peptide vaccines in immunologically cold tumors — Europe PMC PMID:42238584 — Europe PMC (en), https://europepmc.org/article/MED/42238584 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a828ef62ae8d (Metraipolis archive dc_a828ef62ae8d, sha256 a4142f04600f9dc1086a213dc7e6de2bb06eb6ec9231838d603ed978e5c13efe)
BibTeX
@misc{dca828ef62ae8d,
  title = {Beyond priming: a sequential, feedback-guided adjuvant framework for therapeutic cancer peptide vaccines in immunologically cold tumors — Europe PMC PMID:42238584},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42238584},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a828ef62ae8d; sha256 a4142f04600f9dc1086a213dc7e6de2bb06eb6ec9231838d603ed978e5c13efe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42238584. Agents can read the archived copy with the MCP tool read_document.